A Case of Phage Therapy against Pandrug-Resistant <i>Achromobacter xylosoxidans</i> in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with <i>Achr...

Descrizione completa

Dettagli Bibliografici

Autori principali:	David Lebeaux, Maia Merabishvili, Eric Caudron, Damien Lannoy, Leen Van Simaey, Hans Duyvejonck, Romain Guillemain, Caroline Thumerelle, Isabelle Podglajen, Fabrice Compain, Najiby Kassis, Jean-Luc Mainardi, Johannes Wittmann, Christine Rohde, Jean-Paul Pirnay, Nicolas Dufour, Stefan Vermeulen, Yannick Gansemans, Filip Van Nieuwerburgh, Mario Vaneechoutte
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2021-01-01
Serie:	Viruses
Soggetti:	cystic fibrosis lung transplantation antibiotic resistance <i>Achromobacter xylosoxidans</i> bacteriophage therapy
Accesso online:	https://www.mdpi.com/1999-4915/13/1/60
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!